Skip to main navigation Skip to search Skip to main content

Maslinic acid as an effective anticancer agent

  • Xiukun Lin
  • , Ulku Ozbey
  • , Yerzhan Sabitaliyevich Uteuliyev
  • , Rukset Attar
  • , Beraat Ozcelik
  • , Yuanyan Zhang
  • , Mingyue Guo
  • , Minghua Liu
  • , Saleh S. Alhewairini
  • , Ammad Ahmad Farooqi*
  • *Corresponding author for this work
  • Southwest Medical University
  • Munzur Universitesi
  • Kazakhstan Medical University
  • Yeditepe University
  • Qassim University
  • Institute of Biomedical and genetic Engineering (IBGE)

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

Abstract

Maslinic acid (2α,3β-dihydroxyolean-12-en-28-oic acid) is a naturally occurring pentacyclic triterpenic compound. Maslinic acid is gradually gaining attention as an excellent pharmacologically active product because of its premium biological properties. In this review we will focus on chemopreventive properties of Maslinic acid against different cancers. Seemingly, available data is limited and we have yet to unravel how Maslinic acid therapeutically targeted oncogenic cell signal transduction cascades in different cancers. Moreover, there are visible knowledge gaps about the ability of Maslinic acid to modulate oncogenic and tumor suppressor microRNAs in various cancers.

Original languageEnglish
Pages (from-to)87-91
Number of pages5
JournalCellular and Molecular Biology
Volume64
Issue number10
DOIs
Publication statusPublished - 2018

Bibliographical note

Publisher Copyright:
© 2018 by the C.M.B. Association.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Apoptosis
  • Cancer
  • Maslinic acid
  • Signaling

Fingerprint

Dive into the research topics of 'Maslinic acid as an effective anticancer agent'. Together they form a unique fingerprint.

Cite this